Randomized, phase III trial of sequential epirubicin and docetaxel versus epirubicin alone in postmenopausal patients with node-positive breast cancer.
暂无分享，去创建一个
M. Espié | R. Coombes | A. Tres | A. Wardley | F. Erdkamp | J. Bliss | M. Marty | R. Coleman | L. Kilburn | N. Tubiana-Mathieu | P. Hupperets | D. Cooper | J. Reise | K. Wilkinson | J. Wals | M. D. Den Boer | Marina W K Thomas | A. Trés